alpha-aminopyridine has been researched along with Glomerulonephritis, Lupus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chancharoenthana, W; Issara-Amphorn, J; Leelahavanichkul, A; Visitchanakun, P | 1 |
| Bahjat, FR; Deng, GM; Liu, L; Pine, PR; Tsokos, GC | 1 |
2 other study(ies) available for alpha-aminopyridine and Glomerulonephritis, Lupus
| Article | Year |
|---|---|
Syk Inhibitor Attenuates Polymicrobial Sepsis in FcgRIIb-Deficient Lupus Mouse Model, the Impact of Lupus Characteristics in Sepsis.
Topics: Aminopyridines; Animals; Cells, Cultured; Coinfection; Disease Models, Animal; Humans; Inflammation Mediators; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lupus Nephritis; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Oxazines; Pyridines; Pyrimidines; Receptors, IgG; Sepsis; Signal Transduction; Syk Kinase | 2020 |
Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice.
Topics: Aminopyridines; Animals; Disease Models, Animal; Enzyme Inhibitors; Female; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymph Nodes; Mice; Mice, Inbred MRL lpr; Mice, Knockout; Morpholines; Oxazines; Prodrugs; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Skin Diseases | 2010 |